Truist Financial Lowers Astrana Health (NASDAQ:ASTH) Price Target to $46.00
Astrana Health (NASDAQ:ASTH – Get Free Report) had its price objective reduced by equities research analysts at Truist Financial from $50.00 to $46.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 45.99% from the company’s […]
Astrana Health (NASDAQ:ASTH – Get Free Report) had its price objective reduced by equities research analysts at Truist Financial from $50.00 to $46.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 45.99% from the company’s […]
